Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aminopeptidase B (AP-B) is a zinc-dependent exopeptidase enzyme that selectively removes basic residues—specifically arginine (Arg) and lysine (Lys)—from the N-terminus of peptide substrates. It plays a crucial role in the final stages of precursor processing mechanisms, neuropeptide metabolism, and the regulation of bioactive peptides. AP-B is widely distributed across various tissues and intracellular/extracellular locations. Its activity is regulated by zinc ion concentration.
Inhibition of aminopeptidase B activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aminopeptidase B.